Imperative Care’s Zoom Stroke System Studied in M2 Occlusions – Endovascular Today

July 16, 2025—Imperative Care, Inc. announced findings from a subanalysis of patients with M2 occlusions enrolled in the Imperative Trial treate

Read the full article here

Related Articles